Latest News
Adding abiraterone to standard therapy helps people with metastatic prostate cancer to live longer
Adding abiraterone to standard therapy helps people with metastatic prostate cancer to live longer
The REFINE Trial is presented at the European Society for Medical Oncology Congress
The REFINE Trial is presented at the European Society for Medical Oncology Congress
Dolutegravir-based HIV treatment is better for babies and young children
Dolutegravir-based HIV treatment is better for babies and young children
REFINE trial recruits its first participant
REFINE trial recruits its first participant
New meta-analysis method maximises data use to reliably determine which participants benefit most
New meta-analysis method maximises data use to reliably determine which participants benefit most from treatments